NYSE · CVS
Healthcare · Medical - Healthcare Plans
$94.49
Down-$1.06 (-1.11%)
Updated Sep 16, 2026, 11:00 AM
SID Score
5.8/10
Composite research score
Smart Money
62/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CVS closed at $94.49 after 20 trading sessions, down 0.44% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $95.74 | $95.75 | $93.84 | $94.49 | 5M |
| Sep 14, 2026 | $95.44 | $96.01 | $95.28 | $95.55 | 4.45M |
| Sep 11, 2026 | $95.78 | $96.41 | $93.91 | $94.66 | 4.38M |
| Sep 10, 2026 | $96.01 | $97.32 | $94.88 | $95.29 | 3.88M |
| Sep 9, 2026 | $97.39 | $97.98 | $92.7897 | $95.38 | 6.11M |
| Sep 8, 2026 | $95.83 | $96.73 | $95.24 | $96.07 | 4.2M |
| Sep 4, 2026 | $96.59 | $97.69 | $96.285 | $96.74 | 4.5M |
| Sep 3, 2026 | $97.10 | $98.07 | $95.67 | $97.20 | 4.78M |
| Sep 2, 2026 | $97.82 | $98.4999 | $96.90 | $97.23 | 5.4M |
| Sep 1, 2026 | $94.99 | $97.61 | $94.68 | $97.60 | 8.61M |
| Aug 31, 2026 | $93.22 | $94.37 | $92.85 | $93.91 | 10.68M |
| Aug 28, 2026 | $93.40 | $93.93 | $93.01 | $93.06 | 3.99M |
| Aug 27, 2026 | $93.60 | $94.15 | $92.85 | $92.92 | 4.33M |
| Aug 26, 2026 | $93.15 | $94.855 | $92.91 | $94.32 | 6.16M |
| Aug 25, 2026 | $94.11 | $94.11 | $92.71 | $92.90 | 4.1M |
| Aug 24, 2026 | $93.15 | $94.19 | $92.54 | $94.11 | 9.23M |
| Aug 21, 2026 | $94.00 | $94.39 | $92.35 | $93.02 | 5.59M |
| Aug 20, 2026 | $93.23 | $94.26 | $93.21 | $93.65 | 6.44M |
| Aug 19, 2026 | $95.41 | $95.91 | $93.26 | $93.65 | 6.35M |
| Aug 18, 2026 | $94.37 | $95.25 | $93.89 | $94.91 | 6.86M |
The latest Smart Investors Daily articles mentioning CVS.
CVS research
Company profile and research snapshot.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 3, 2026 | UBS | Buy | — |
| Aug 19, 2026 | Argus Research | Buy | — |
| Aug 12, 2026 | JP Morgan | Overweight | — |
| Aug 6, 2026 | Evercore ISI Group | Outperform | — |
| Aug 6, 2026 | UBS | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 10, 2026
Appointments can be scheduled through the app or CVS.com and walk-ins are acceptedOriginally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 10, 2026 / ® (NYSE:CVS) announced that updated 2026-2027 COVID-19 vaccines are now available at CVS Pharmacy® and MinuteClinic® locations for patients at no-cost with most insurance plans.
SeekingAlpha · Sep 10, 2026
CVS Health looks undervalued at 12x forward P/E as revenue and operating income rebound; learn key catalysts, risks, and why a Buy may fitâread now.
SeekingAlpha · Sep 10, 2026
CVS Health Corporation (CVS) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 9:30 AM EDTCompany ParticipantsBrian Newman - Executive VP...
Yahoo · Sep 9, 2026
Originally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 9, 2026 / New survey findings commissioned by ® (NYSE:CVS) reveal that many Americans face persistent barriers accessing preventive health screenings. Nearly one in four adults have delayed speaking with a health professional about health concerns because of barriers related to access, cost or availability, and one-third were unaware that community screening programs exist.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CVS.
